Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents

Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents

Bibliographic Details
Main Authors:	Maria Ödling, Ann‐Charlotte Sundqvist, Josef Brandström, Anna Nopp, Niklas Andersson, Caroline Nilsson, Inger Kull
Format:	Article
Language:	English
Published:	Wiley 2023-02-01
Series:	Clinical and Translational Allergy
Online Access:	https://doi.org/10.1002/clt2.12225

Similar Items

Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible.
by: Susanne Glaumann, et al.
Published: (2013-01-01)

Peanut thresholds in peanut‐allergic children are related to dietary composition
by: Daisy Luiten, et al.
Published: (2023-05-01)

Transitioning from epicutaneous to oral peanut immunotherapy
by: Lauren Wong, et al.
Published: (2023-02-01)

Interpreting success or failure of peanut oral immunotherapy
by: Shijie Cao, et al.
Published: (2022-01-01)

Oral immunotherapy for peanut allergy: The pro argument
by: R. Sharon Chinthrajah, et al.
Published: (2020-08-01)

Transitioning peanut oral immunotherapy to clinical practice
by: S. Lazizi, et al.
Published: (2022-08-01)

Peanut allergy: Beyond the oral immunotherapy plateau
by: Kelly Bruton, et al.
Published: (2021-08-01)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
by: J. Andrew Bird, MD, et al.
Published: (2023-08-01)

Insights into Microbiome and Metabolic Signatures of Children Undergoing Peanut Oral Immunotherapy
by: Andrea C. Blackman, et al.
Published: (2022-08-01)

Risk factors associated with safety of preschool peanut oral immunotherapy
by: Duva Karunakaran, BSc, et al.
Published: (2023-05-01)

Study of induction of Tolerance to Oral Peanut: a randomised controlled trial of desensitisation using peanut oral immunotherapy in children (STOP II)
by: Katherine Anagnostou, et al.
Published: (2014-12-01)

A murine model of peanut-allergic asthma
by: Marta Paolucci, et al.
Published: (2024-04-01)

Risk Factors for Anaphylaxis in Children Allergic to Peanuts
by: Tadej Petek, et al.
Published: (2023-05-01)

Treatment of allergic reactions to peanut in recent versus initial reaction
by: Ben-Shoshan Moshe, et al.
Published: (2010-11-01)

Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age
by: Natasha Bear, et al.
Published: (2023-12-01)

Peanut sensitization in a group of allergic Egyptian children
by: Hossny Elham, et al.
Published: (2011-05-01)

Viral Vector Based Immunotherapy for Peanut Allergy
by: Miguel Gonzalez-Visiedo, et al.
Published: (2024-07-01)

Children and caregiver proxy quality of life from peanut oral immunotherapy trials
by: Audrey Dunn Galvin, et al.
Published: (2022-12-01)

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells
by: Brinda Monian, et al.
Published: (2022-01-01)

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children
by: Janne Burman, et al.
Published: (2022-10-01)

Health-related quality of life decreases in young people with asthma during the transition from adolescence to young adulthood: a birth cohort study
by: Maria Ödling, et al.
Published: (2023-01-01)

Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial
by: Li Huang, et al.
Published: (2023-12-01)

Risk Assessment of Clinical Reactions to Legumes in Peanut-Allergic Children
by: Louise Bjerremann Jensen, et al.
Published: (2008-01-01)

Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand
by: Naphisabet Wanniang, et al.
Published: (2023-10-01)

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice
by: Jay Portnoy, et al.
Published: (2022-05-01)

Current trends in peanut allergy immunotherapy: a review
by: Klementyna Łyżwa, et al.
Published: (2024-04-01)

Rhizoma Perennial Peanut
by: Mary J. Williams, et al.
Published: (2011-07-01)

Rhizoma Perennial Peanut
by: Mary J. Williams, et al.
Published: (2011-07-01)

Rhizoma Perennial Peanut
by: Mary J. Williams, et al.
Published: (2011-07-01)

Roasting enhances peanut allergic sensitisation across mucosal and cutaneous routes
by: Moghaddam, A, et al.
Published: (2013)

Influence of Peanut Varieties on the Sensory Quality of Peanut Butter
by: Tapiwa Reward Sithole, et al.
Published: (2022-11-01)

IgE and IgG4 epitopes of the peanut allergens shift following oral immunotherapy
by: Ian M. Rambo, et al.
Published: (2023-11-01)

Qualitative interviews to understand health care providers’ experiences of prescribing licensed peanut oral immunotherapy
by: Aikaterini Anagnostou, et al.
Published: (2022-08-01)

Peanut butter
by: 982 SIRIM

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
by: Michael O’Sullivan, et al.
Published: (2020-09-01)

Differences in Linear Epitopes of Ara h 9 Recognition in Peanut Allergic and Tolerant, Peach Allergic Patients
by: L. Sánchez-Ruano, et al.
Published: (2022-07-01)

Egg introduction during complementary feeding according to allergic risk: not just for peanuts!
by: Elvira Verduci, et al.
Published: (2018-07-01)

BSACI guidance for the implementation of Palforzia® peanut oral immunotherapy in the United Kingdom: a Delphi consensus study
by: Marrs, Tom, et al.
Published: (2024)

Safety of oral immunotherapy for cashew nut and peanut allergy in children – a retrospective single-centre study
by: Maria Breiding, et al.
Published: (2024-11-01)

Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy.
by: Sara Anvari, et al.
Published: (2022-01-01)